Sen. Chuck Grassley called on the Trump administration on Oct. 2, 2026, to finalize a proposed federal rule targeting 7-hydroxymitragynine (7-OH) above a specified threshold. That is not the same as a completed blanket ban on all kratom: federal agencies say the proposed 7-OH action is aimed at concentrated or synthetic products, not natural kratom leaf containing only trace naturally occurring 7-OH.
What Grassley called for
A report by The Hill, republished by AOL, says Grassley called on Friday, Oct. 2, 2026, for the administration to finalize a proposed rule concerning 7-OH. The report characterizes the July 2026 DEA proposal as temporarily scheduling 7-OH above a specified threshold as a Schedule I substance.
As an Amazon Associate I earn from qualifying purchases.
The proposal is not itself a final scheduling order. HHS said on July 1, 2026, that agencies had issued notices of intent to begin temporary scheduling processes for 7-OH above a specified threshold and three related substances. Its release described a 30-day public comment period on the proposed 7-OH threshold and said the Attorney General may issue a temporary order after the statutory waiting period and consideration of comments. The call reported on Oct. 2 was to finalize that proposed action, not evidence that a final order had already taken effect.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →What the proposed 7-OH action would cover
The word “kratom” can obscure important differences in the substances and products involved. FDA says the contemplated 7-OH action is intended to target concentrated and synthetic products and is not intended to apply to natural kratom leaf with only trace, naturally occurring 7-OH. HHS Secretary Robert F. Kennedy Jr. said July 1, 2026: “These actions are not intended to regulate natural leaf kratom that does not contain enhanced levels of 7-OH.” DEA Administrator Terrance Cole said the same day: “Today’s action targets highly concentrated, synthetic 7-OH products, which pose a growing threat to public safety and health.”
#1 Best Overall
- Easy to Fill - Whether you like to manually fill your caps or use a capsule filling machine, pill press, or by hand, our size 00 empty vegetarian capsules are designed with tough anti-break conisnap rounded ends and are transparent to make filling capsules size 00 easier than ever. Our clear size 00 capsules hold 600mg to 1100mg of powdered supplements depending on density.
- Snap Shut Design - Our expertly engineered click shut design ensures you don't waste any of your valuable powders, herbs or ingredients during or after filling your gel capsules empty. The click shut feature also helps protect the contents of your vegetable capsules empty from humidity and air. Have peace of mind knowing that your vegan empty capsules are secure.
- Easy to Digest - Each veg capsule is made from 100 percent HPMC vegetable cellulose and will dissolve in your gastrointestinal tract for maximum absorption of your supplement ingredients. These veggie caps contain no additives or preservatives.
- Choose our convenient 1000 count option. At XPRS Nutra, we go the extra mile to help you attain the highest quality vegan capsules empty 00 pill filler to use with your powders, nootropics and veggie capsules. Our veggie pills capsule filling kit is here to help make your life easier.
- Subscribe and Save - We know you'll love the quality and convenience of our capsules size 00. We source from trusted suppliers and process all of our inventory in Utah, USA. Up your health game this year with our separated pill capsules empty size 00.
- Natural kratom leaf: FDA’s stated intention is not to include leaf with only naturally occurring trace 7-OH.
- Concentrated or synthetic 7-OH products: These are the stated focus of the proposed threshold action.
- Other synthetic or related substances: Mitragynine pseudoindoxyl, MGM-15 and MGM-16 are separate compounds; HHS says they do not naturally occur in the kratom plant.
Accordingly, a proposal addressing products with enhanced 7-OH levels should not be described as a completed prohibition of every product derived from kratom leaf.
Related compounds have a separate scheduling process
A July 6, 2026, Federal Register notice concerns the temporary placement of mitragynine pseudoindoxyl, MGM-15 and MGM-16 in Schedule I. It is a notice of intent, distinct from a temporary order. The notice says a resulting temporary order would take effect upon publication, last two years and be eligible for a one-year extension.
The Oct. 2 report says DEA announced emergency scheduling of MGM-15 and MGM-16 in August. The notice’s proposed process and a later order are different procedural steps; the report’s account alone does not establish the precise current legal status of each compound. For a current answer, check DEA and the Federal Register for any orders published after the notice.
What FDA says about kratom’s health and market status
FDA says no kratom-containing drug products are legally on the U.S. market and that kratom is not lawfully marketed as a drug, dietary supplement or conventional food ingredient. FDA warns of serious adverse events, including liver toxicity, seizures and substance use disorder. It also says some deaths have been associated with kratom use, usually alongside other drugs, while noting that kratom’s contribution in those cases is unclear. These are FDA’s stated regulatory and safety positions; they are not a conclusion that every reported adverse event was caused by kratom.
FDA also says it has warned consumers about kratom products contaminated with Salmonella or containing concerning levels of heavy metals. The agency reported that seven companies received warning letters over products containing 7-OH in July 2025. Separately, HHS reported that approximately $1 million in unlawful 7-OH dietary supplement and food products was seized from three Missouri firms in December 2025.
Federal action does not settle state legality
State regulations or prohibitions may also apply, according to FDA. State rules can differ, so a national news report is not enough to determine whether a particular product is lawful in a particular location. For a state-specific answer, check the relevant state health department or law-enforcement agency and the current federal notices or orders.
Rank #4
- The information below is per-pack only
- 120 Capsules (60 Servings) of High Quality Agmatine Sulfate Per Bottle
- Up to 1000mg Per Serving (500mg Per Capsule)
- Great To Use During Pre/Post Workouts
- Non-GMO, Gluten Free, 3rd Party Tested
What the available figures do—and do not—show
FDA reports that the Substance Abuse and Mental Health Services Administration estimated 1.7 million Americans aged 12 and older used kratom in 2021, based on the 2021 National Survey on Drug Use and Health. This is a dated survey estimate, not a count of current users. The Hill/AOL report also attributes a 1,200 percent increase in kratom-related exposure reports from 2015 to 2025 to CDC, but that figure is presented through the news report rather than the original CDC publication and should not be treated as a verified measure of kratom use or harm on its own.
How to read the headline
“Ban kratom ‘NOW’” is headline shorthand for Grassley’s reported demand that the administration finalize a proposed rule. The actual federal actions described here involve specific compounds, thresholds and procedural steps—not one completed, across-the-board federal ban on natural kratom leaf. For consumers, the relevant distinctions are the product’s chemical composition and whether the applicable rule is a proposal, notice of intent, published temporary order or another law.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
